Global Next Generation Sequencing Market to 2025
www.theinsightpartners.com
The next generation sequencing market is estimated to grow at a CAGR of 21.1% during
the forecast period from 2018 to 2025. The next generation sequencing market is
estimated to reach US$ 26,501.25 Mn by 2025.
Next generation sequencing (NGS) is the technology which is used to align millions of small
fragments of DNA simultaneously that are capable of processing multiple DNA sequences in
parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and
medical research and discovery. The demand for next generation sequencing technology has been
increasing widely due to the rise in genetic tests. The availability of next generation sequencing at
low cost, technological advancements and high prevalence of cancer cases during the previous
years. Also, the companies operating the next generation sequencing market have been investing
substantial time and amount in research and development activities, through which better
technologies can be introduced in the market.
Get Sample Report at https://www.theinsightpartners.com/sample/TIPHE100000820
In our study, we have segmented the next generation sequencing market by product, service,
application and end-users. The products considered in the study are platform, services, and
consumables. The platform segment is further segmented as Hiseq, Miseq, Solid, ION Torrent,
Pacbio Rs II & Sequel Systems. The sub-segment of services is further divided as sequencing
services and data management & analysis services. Consumables is further bifurcated as sample
preparation consumables, library preparation & target enrichment kits & reagents, and quality
control kits & reagents. The services segment is classified as genome sequencing. Exome
sequencing, resequencing & targeted sequencing, and other services. The applications of next
generation sequencing covered in the report include, diagnostics, drug discovery, precision
medicine, and others. The end-users of next generation sequencing is classified as academic &
research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and others.
Geographically, the market for next generation sequencing is categorized as North America,
Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).
The next generation sequencing market is witnessing a healthy growth rate during the previous
years and is expected to witness similar trend in the coming years. The companies operating in the
market of next generation sequencing provide their products and services for applications such as
drug discovery, diagnosis, and precision medicine. With constant R&D activities, the companies
have been focusing towards developing advanced techniques in next generation sequencing that
can be useful for end users such as hospitals & clinics, academic institutions, etc. Various players
have been upgrading their product portfolio by applying for approvals. With expansion activities,
companies are focusing towards strengthening their customer base by providing services to varied
applications.
The next generation sequencing market is well established in North America region, especially in
the U.S and Canada. Companies are engaging in expansion activities in order to strengthen their
customer presence in the region of North America, For instance, Illumina, Inc. and Telegraph
together launched a new company, Verogen, which would provide Illumina’s forensic sequencing
technology to forensic customers in the US. Advancements in technologies and declining prices are
considered to be the driving factors in the next generation sequencing market.
The major players operating in the market of next generation sequencing market include F.
Hoffmann-La Roche AG, PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Eurofins Scientific,
Thermo Fisher Scientific, Beijing Genomics Institute, Agilent Technologies, Qiagen N.V., Macrogen,
Inc., and Illumina, Inc. among others
Have Queries? Ask us at https://www.theinsightpartners.com/inquiry/TIPHE100000820
2